ClinConnect ClinConnect Logo
Search / Trial NCT01877499

Can High Convection Volumes be Achieved in Each Patient During Online Post-dilution Hemodiafiltration?

Launched by AMSTERDAM UMC, LOCATION VUMC · Jun 10, 2013

Trial Information

Current as of May 20, 2025

Completed

Keywords

Hemodiafiltration Convection Volume Filtration Fraction Blood Flow Treatment Time

ClinConnect Summary

Hemodialysis (HD) is the most common used renal replacement therapy worldwide. The main objective is the removal of excess fluid and toxic solutes from the patient. Despite the relative efficiency of modern dialyzers, HD remains inferior to normal kidney function, in part because of the inadequate clearance of so-called 'middle molecules'. In other words, 'uremic toxins' accumulate in chronic HD patients.

The role of middle molecular weight uremic toxins in the pathogenesis of many co-morbid conditions associated with end-stage renal disease is increasingly recognized. Hence, the hypothesi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients treated with HD or HDF since \>6 weeks, 3 times a week;
  • Patients able to understand the study procedures;
  • Patients willing to provide written informed consent.
  • Exclusion Criteria:
  • Current age \< 18 years;
  • Severe incompliance to dialysis procedure and accompanying prescriptions (frequency and duration of dialysis treatment and fluid restriction);
  • Life expectancy \< 3 months due to non-renal disease.

About Amsterdam Umc, Location Vumc

Amsterdam UMC, located at VU Medical Center (VUmc), is a leading academic medical center in the Netherlands dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on translating scientific discoveries into practical applications, Amsterdam UMC collaborates closely with researchers, healthcare professionals, and industry partners to enhance patient outcomes. The institution is committed to rigorous ethical standards and regulatory compliance, ensuring the integrity and reliability of its clinical research initiatives across various medical disciplines.

Locations

Utrecht, , Netherlands

Amsterdam, , Netherlands

Eindhoven, , Netherlands

Groningen, , Netherlands

Rotterdam, , Netherlands

Amsterdam, , Netherlands

Amsterdam, , Netherlands

Patients applied

0 patients applied

Trial Officials

Peter J Blankestijn, MD PhD

Study Director

UMC Utrecht

Michiel L Bots, MD PhD

Study Director

Julius Center for Health Sciences and Primary Care, UMC Utrecht

Marinus A van den Dorpel, MD PhD

Study Director

Maasstad Hospital, Rotterdam

Menso J Nubé, MD PhD

Study Chair

Amsterdam UMC, location VUmc

Piet M ter Wee, MD PhD

Study Director

Amsterdam UMC, location VUmc

Muriel PC Grooteman, MD PhD

Principal Investigator

Amsterdam UMC, location VUmc

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials